ESC 365 - Blood pressure measurement: how does the decline translate to CV risk reduction?

Open Access

Blood pressure measurement: how does the decline translate to CV risk reduction?

Session: Renal denervation (RDN) for uncontrolled hypertension: introducing the SPYRAL HTN global clinical trial program

Topic: Renal denervation

Speaker: Professor G. Mancia (Milan, IT)

Sponsored by Medtronic

Event: ESC Congress 2015

Congress Presentation

Add to my library

About the speaker

Professor Giuseppe Mancia

University of Milan Bicocca, Milan (Italy)

26 presentations

6 followers

5 more presentations in this session

Brief history of RDN.

Speaker: Professor F. Mahfoud (Basel, CH)

Anatomical Optimization of renal denervation: Have we found the “sweet spot”?

Speaker: Professor F. Mahfoud (Basel, CH)

Addressing the confounding effect of dynamic drug therapy adherence in clinical trial design.

Speaker: Professor P. Blankestijn (Utrecht, NL)

Population variability: have we identified the correct population for renal denervation therapy?

Speaker: Doctor J. Davies (London, GB)

Introducing the SPYRAL HTN global clinical program and audience Q&A.

Speaker: Professor M. Boehm (Homburg, DE)

Access the full session

Renal denervation (RDN) for uncontrolled hypertension: introducing the SPYRAL HTN global clinical trial program

Speakers: Professor G. Mancia, Professor F. Mahfoud, Professor F. Mahfoud, Professor P. Blankestijn, Doctor J. Davies...

About the event

ESC Congress 2015

29 August - 2 September 2015

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources